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ABSTRACT 
Salmonella enterica serovar Typhi (S. Typhi) is a human restricted pathogen. It biosynthesizes a virulence capsu-
lar polysaccharide named as Vi antigen. S. Typhi regulates expression of genes involved in the biosynthesis of 
Vi antigen in response to osmolarity. Beside Vi-positive isolates, Vi-negative (acapsulated) isolates are also 
pathogenic. However, Vi-positive isolates are more prevalent. The present study was planned to investigate 
comparative growth of Vi-positive and Vi-negative S. Typhi isolates in an ex vivo human whole blood model. 
Four isolates of each type were tested for growth in human whole blood and in an enrichment medium (Tryptic 
soy broth-TSB) as a control. It was found that capsulated (Vi-positive) strains formed smooth circular colonies 
and grew with shorter lag and generation time than Vi-negative isolates. Overall growth pattern of S. Typhi iso-
lates both in vitro and ex vivo conditions showed that Vi-positive isolates grew at a faster rate. Especially in hu-
man blood, the lag time of acapsulated isolates was almost doubled as compared to capsulated S. Typhi isolates. 
It was also observed that Vi-negative isolates reduced in number up to 81 % during the first 12 hours of incuba-
tion in human whole blood. Interestingly, both types of isolates had similar growth curve in TSB indicating that 
Vi capsule is dispensable for bacterial growth in vitro. This study shows for the first time that absence of capsu-
lar antigen retards the growth of Vi-negative isolates on initial contact with human blood, but with passage of 
time they adjust themselves according to the new environment. 
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INTRODUCTION 
Salmonella enterica serovar Typhi is an 
exclusively human pathogen and a leading 
cause of enteric fever worldwide. It causes 
an acute, systemic infection of the reticulo-
endothelial system. Our knowledge of the 
actual mechanism of pathogenesis of S. 
Typhi is limited because it infects only hu-
mans, which means that animal models are 
not available to study host-pathogen interac-
tions. Most of the current understandings 
about the pathogenicity of S. Typhi have 
been extrapolated from S. Typhimurium in-
fections in mice. A major limitation for using 
this murine model is that S. Typhimurium 
does not cause typhoid fever in humans but 
instead causes a localized gastroenteritis re-
sulting in diarrhea. S. Typhi produces a viru-
lence factor, the Vi capsular antigen which is 
absent in S. Typhimurium. Vi capsule is syn-
thesized by genes located on a large patho-
genecity island designated as SPI-7 which is 
not present in the genome of S. Typhimuri-
um. SPI-7 is genetically unstable (Bueno et 
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al., 2004; Nair et al., 2004) and its deletion 
may give rise to acapsulated S. Typhi iso-
lates. Therefore, on the basis of capsule for-
mation, S. Typhi can be grouped into two 
types: capsulated (Vi-positive) and acapsu-
lated (Vi-negative). Both types have been 
identified and isolated from typhoid patient’s 
blood (Baker et al., 2005; Pulickal et al., 
2013; Wain et al., 2005) and volunteer stud-
ies have shown that both can cause enteric 
fever (Hone et al., 1988).  
During the course of infection, Vi capsu-
lar antigen protects bacteria against host im-
mune system due to its anti-inflammatory 
(Crawford et al., 2013; Haneda et al., 2009; 
Raffatellu et al., 2007), antiopsonic and an-
tiphagocytic property (Wilson et al., 2011). 
The expression of genes involved in the Vi 
capsular biosynthesis is greatly influenced 
by the environmental conditions. The osmo-
larity of the lumen of small intestine is 
equivalent to 0.3 M NaCl (Sleator et al., 
2007) and bacterial exposure to this high 
osmolarity results in drastic decrease in the 
expression of Vi antigen (Tartera and 
Metcalf, 1993; Tran et al., 2010). It is ex-
pressed when S. Typhi transits from intesti-
nal lumen into the ileal mucosa under low 
osmolarity environment which may explain 
the protective role of capsule during system-
ic infection. 
Role of Vi antigen in survival of S. Typhi 
has been studied using macrophage (Size-
more et al., 1997; Wilson et al., 2011), neu-
trophil (Wangdi et al., 2014) and epithelial 
cell lines. The role of Vi antigen in serum 
resistance has also been reported (Bravo et 
al., 2008; Looney and Steigbigel, 1986). 
However, during infection, the behavior of 
capsular and acapsular variants of S. Typhi 
in whole human blood is still in question. 
Two conflicting reports have described the 
role of Vi antigen in protection of S. Typhi 
from inhibitory effect of human serum 
(Bravo et al., 2008; Looney and Steigbigel, 
1986). According to Looney and Steigbigel 
(1986), Vi-positive strains are more resistant 
to lysis by non-immune serum than Vi-
negative isolates, whereas Bravo et al. 
(2008) demonstrated that the Vi antigen does 
not contribute to serum resistance. 
This study is based on the comparative 
growth behavior of Vi-negative and Vi-
positive variants of S. Typhi in human whole 
blood as an ex vivo model. This comparative 
study on survival and growth of naturally 
occurring Vi-negative and Vi-positive S. 
Typhi strains was conducted to investigate 
whether Vi antigen expression is enhanced 
within human blood due to low osmolarity 
conditions, and consequently there are dif-
ferent growth rates of Vi-negative and Vi-
positive S. Typhi isolates in blood.  
 
MATERIALS AND METHODS 
Bacterial strains 
Four Vi-positive and four Vi-negative 
S. Typhi isolates cultured from blood sam-
ples of typhoid patients were investigated in 
this study. Blood samples were collected 
from different patients suffering from ty-
phoid fever in various hospitals in Faisalabad 
region of Pakistan. All isolates were revived 
from National Institute for Biotechnology 
and Genetic Engineering (NIBGE) stocks 
stored in 20 % glycerol at -20 °C (Baker et 
al., 2005). 
 
In vitro growth analysis 
Tryptic soy broth (TSB), a universal cul-
ture medium free from inhibitors and indica-
tors with osmolarity (300 mosmol/liter) simi-
lar to human blood (Scharfman et al., 1996), 
was used for reviving the S. Typhi stock cul-
tures for in vitro growth analysis. Growth in 
TSB was subcultured on MacConkey agar. A 
single colony was reinoculated in 3 ml TSB 
and cultured at 37 °C with shaking at 
200 rpm for at least 18 hours. Fifty µl of this 
overnight culture were inoculated into 3 ml 
of fresh TSB and cultured at 37 °C with 
shaking at 200 rpm. At time points of 0, 2, 4, 
6, 8, 10, 12, 14, 16, 18 and 24 hours after 
inoculation, samples of bacterial cultures 
were collected and used for analysis after 
making ten fold serial dilution in autoclaved 
distilled water. The CFU were quantified by 
plating the appropriate dilutions on Mac-
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Conkey agar. Each sample was analyzed in 
triplicate and the analysis was repeated at 
least three times. The bacterial counts were 
transformed into logarithms and their aver-
age values of CFU/ml were used to plot the 
growth curve. The generation time was de-
termined by comparing bacterial cell num-
bers at two time points of the exponential 
growth phase using following formula (Liu 
et al., 2006): 
Generation time = 0.301 (T2 - T1) / (logN 
- logN0) 
T1 is the first time point (minutes) and T2 
is the second time point of the exponential 
phase, N0 is the number of bacterial cells at 
T1, and N is the number of bacterial cells at T2. 
 
Human whole blood as ex vivo growth 
model 
Human whole blood has been used as an 
ex vivo model for studying the human re-
stricted pathogens including Neisseria men-
ingitidis, Listeria monocytogenes, and group 
A and group B Streptococcus species 
(Echenique-Rivera et al., 2011; Graham et 
al., 2005; Mereghetti et al., 2008; Toledo-
Arana et al., 2009). S. Typhi is also a human 
restricted pathogen. Therefore, in this study 
human blood from healthy volunteers was 
used as ex vivo model for comparative 
growth analysis of Vi-negative and Vi-
positive S. Typhi isolates with that of TSB 
medium (as in vitro model). Human venous 
blood was collected (in heparin) from 4 
healthy volunteers (two males and two fe-
males, ages ranged from 25 to 35 years) who 
were not on any antimicrobial treatment for 
the past eight months before this study.  
Bacterial loads in typhoid patients can 
reach up to 104 bacteria/ml (Massi et al., 
2005; Wain et al., 2001). Therefore, approx-
imately 103 bacteria from early exponential 
phase culture within TSB were mixed with 
heparinized blood from each donor separate-
ly and cultured at 37 °C with shaking at 
200 rpm. To check the S. Typhi adaptation in 
human blood, samples were collected at five 
different time points (each time point con-
sisted of triplicate culture): time 0 (immedi-
ately after mixing bacteria with blood), and 
after 12, 24, 48 and 72 hours incubation at 
37°C with shaking at 200 rpm and used for 
analysis by serial dilution as in case of in 
vitro growth analysis. Human blood from 
each donor without bacterial inoculum was 
used as negative control during viable bacte-
rial cell enumeration experiment. 
 
Statistical analysis 
Two-way ANOVA with Bonferroni post-
test was used for the statistical analysis. The 
statistical analysis was performed using 
GraphPadPrism5 with the significance set at 
a P of <0.05.  
 
RESULTS 
Growth analysis of Vi-negative and Vi-
positive S. Typhi isolates in TSB medium 
and human blood from four different donors 
over time course of 72 hours revealed that 
Vi-positive isolates have significantly shorter 
lag and generation times as compared to Vi-
negative strains (Table 1). Vi-positive iso-
lates grew at much faster rate as compared to 
Vi-negative isolates. In human whole blood, 
the lag time of Vi-negative isolates was dou-
bled as compared to Vi-positive isolates. The 
viable cell density (CFU/ml) of S. Typhi 
capsulated strains (Vi-positive) was in-
creased approximately 14 fold during 12 
hours of incubation in blood. Contrasting 
growth pattern was observed in case of acap-
sulated isolates (Vi-negative). There was a 
fivefold (81 %) reduction in numbers after 
the first 12 hours of incubation in human 
blood (Figure 1B). They also showed differ-
ent colonial morphology on MacConkey 
agar. Vi-positive isolates grew in the form of 
smooth circular colonies whereas Vi-nega-
tive isolates had circular colonies with rough 
boundaries having similar sizes (approxi-
mately 2-3 mm within 48 hours of incuba-
tion). On the whole, bacterial numbers in-
creased approximately 104 (Vi-negative iso-
lates) and 105 (Vi-positive isolates) over an 
incubation period of 72 hours in human 
blood. The bacterial count pattern for Vi-
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positive isolates was similar in blood of four 
donors. It was also similar in case of Vi-
negative isolates (Figure 2) indicating repro-
ducibility of the results. 
 
Table 1: Behavior of Vi-negative and Vi-positive 
isolates of Salmonella Typhi populations incu-
bated at 37 °C in TSB and human blood 
Growth curve values Vi- Vi+ 
Lag time (in hours) 
in TSB 10 8 
Lag time (in hours) 
in blood 48 24 
Generation time  
(in min) in TSB 34.73 12.72 
Generation time  
(in min) in blood 102 72.24 
Maximum popula-
tion density (log-
CFU/ml) in TSB 
9.01±0.586 9.5±0.119 
Maximum popula-
tion density (log-
CFU/ml) in blood 
7.4±0.066 8.95±0.016 
Colony morphology 
on MacConkey agar 
Rough  
circular 
Smooth 
circular 
 
DISCUSSION 
Vi capsular polysaccharide has been 
known as a virulence factor of S. Typhi for 
the last several decades. This virulence anti-
gen is expressed by S. Typhi, Citrobacter 
fruendii, and some other serogroups of Sal-
monellae. In recent years, the old dogma that 
virulence of S. Typhi is essentially related to 
production of Vi antigen is shaken with the 
reports of Vi negative but pathogenic strains 
emerging from all over the world (Baker et 
al., 2005; Hone et al., 1988; Mehta and Arya, 
2002; Pulickal et al., 2013; Wain et al., 
2005). The potential of Vi negative strains to 
cause typhoid fever is now an established 
fact but the differences is the growth and 
survival of Vi negative and Vi positive vari-
ants during infection is still not clear.  
The Vi capsule is a protective component 
of S. Typhi and its role in intracellular sur-
vival of S. Typhi and in serum resistance has 
been recently reported (Hirose et al., 1997; 
Looney and Steigbigel, 1986). It is desirable 
to analyze the effect of absence of this pro-
tective antigen during natural infection. The 
comparative analysis of the growth patterns 
of Vi-positive and Vi-negative S. Typhi iso-
lates in a model mimicking conditions of 
natural infection can be a method of choice. 
In this study, human whole blood is selected 
as an ex vivo model because of its ability to 
mimic the behavior of S. Typhi growth in 
host, in response to cellular and humoral 
bactericidal mechanisms. 
Considering previous reports about se-
rum resistance in the presence of capsular Vi 
antigen (Bravo et al., 2008; Looney and 
Steigbigel, 1986), we investigated effect of 
the presence of Vi antigen on the bacterial 
survival and growth in human whole blood. 
Our results showed that presence of capsule 
affects growth of bacteria in human blood 
because capsulated isolates grow at a faster 
rate as compared to acapsulated isolates and 
they maintain sustainable growth. The lag 
time of Vi-negative isolates was double as 
compared to Vi-positive isolates. In case of 
Vi negative isolates, live cell density (CFU/ 
ml) decreased about five fold within the first 
12 hours of incubation in blood. It means 
that acapsulated isolates take longer time to 
adapt to blood environment where as capsu-
lated isolates promptly acclimatize them-
selves due to presence of additional protec-
tive tool in the form of capsule. This is the 
major difference in survival and growth of 
Vi-negative and Vi-positive isolates in hu-
man blood as compared to TSB medium 
(Figure 1A, B). Therefore, it may be con-
cluded that absence of capsule affects the 
survival and growth of Vi-negative isolates 
in human blood. Additionally, as expected 
from the analysis of blood from four differ-
ent volunteers, overall survival pattern of 
both types of S. Typhi isolates remained con-
sistent (Figure 2). Thus our results do not 
agree with a previous study indicating that 
presence of Vi capsule does not affect bacte-
rial resistance to factors present in human 
blood (Bravo et al., 2008). Our results 
showed a marked difference in survival and 
growth of capsulated and acapsulated iso-
lates in blood within the first 12 hours of in-
cubation. 
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Figure 1: Growth of Vi-negative and Vi-positive S. Typhi isolates in TSB medium (A) and human 
whole blood(B) 
 
 
 
Figure 2: Growth of Vi-negative (A) and Vi-positive (B) S. Typhi isolates in human whole blood from 
four donors 
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Looney and Steigbigel (1986) found that 
Vi-negative S. typhi isolates were extremely 
sensitive to non immune human serum and 
more than 99 % of bacterial cells were lysed 
within 40 minutes of their exposure to hu-
man serum. Our results support this report, 
although we found only 81 % reduction in 
viable Vi-negative bacteria during the first 
12 hours of incubation in human blood. An-
other report by Hirose et al. (1997) pointed 
out that both types of S. Typhi strains can 
survive in resting macrophages although 
growth of acapsulated strains was inhibited. 
Neither Vi-positive nor Vi-negative S. Typhi 
survived in the activated human macrophag-
es and only Vi-positive S. Typhi replicated 
inside resting macrophages as compared to 
Vi-negative strain (Hirose et al., 1997). Our 
results support this finding and highlight the 
protective role of Vi capsule. 
In brief, we can say that absence of cap-
sule does not only affect survival but also 
retard bacterial growth especially during the 
first 12 hours of incubation in human blood. 
It is probable that Vi-negative bacteria use 
some alternative strategies to protect them-
selves. To best of our knowledge, this is the 
first report regarding comparative growth 
analysis of Vi-positive and Vi-negative S. 
Typhi in whole human blood. Thus it can be 
concluded from the study that the absence of 
Vi capsular polysaccharide affects the sur-
vival of bacteria within human whole blood 
transiently but can critically affect its growth 
rate during the course of infection. 
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